A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 124 years in the city of Embu das Artes, São Paulo, Brazil
Braz J Infect Dis
; 27(6): 1-9, 2023.
Artigo
em Português
| Sec. Est. Saúde SP, SESSP-IALPROD, Sec. Est. Saúde SP
| ID: biblio-1428068
Biblioteca responsável:
BR91.2
Localização: BR91.2; P
ABSTRACT
Meningococcal carriage is a prerequisite for invasive infection. This cross-sectional study assessed the pharyngeal carriage prevalence in healthy subjects aged 124 years in Embu das Artes city, São Paulo, Brazil. Pharyngeal swabs were examined for the presence of Neisseria meningitidis. The isolates were tested for different serogroups using agglutination and polymerase chain reaction. A logistic regression model assessed any independent association between Neisseria meningitidis carriage and various risk factors. A total of 87/967 subjects (9%, 95% Confidence Interval (CI) 7.311.0) tested positive for N. meningitidis 6.2% (95% CI 3.89.4) in 14 years, 8.5% (95% CI 5.113.0) in 59 years, 12.5% (95% CI 7.818.6) in 1014 years, 12.6% (95% CI 7.419.7) in 1519 years and 9% (95% CI 4.914.9) in 2024 years age groups. Highest carriage prevalence was observed in adolescents 1019 years old. Serogroup C was predominant (18.4%) followed by serogroup B (12.6%). The 1519 years age group showed a significant association between number of household members and carriers of N. meningitidis. This cross-sectional study is the first in Brazil to evaluate meningococcal carriage prevalence and associated factors in a wide age range.
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Brasil
Base de dados:
Sec. Est. Saúde SP
/
SESSP-IALPROD
Assunto principal:
Estudos Transversais
/
Neisseria meningitidis
Tipo de estudo:
Estudo observacional
/
Estudo de prevalência
/
Estudo prognóstico
/
Fatores de risco
País/Região como assunto:
América do Sul
/
Brasil
Idioma:
Português
Revista:
Braz J Infect Dis
Ano de publicação:
2023
Tipo de documento:
Artigo
Instituição/País de afiliação:
GSK Brazil, Rio de Janeiro/BR
/
GSK, Bangalore, India/BR
/
GSK, Ciudad de Panama, Panama/BR
/
Instituto Adolfo Lutz/BR
/
Universidade Federal de São Paulo/BR